Studies on the cyclic AMP response to prostaglandin in human lymphocytes

James S. Goodwin, Shirley Bromberg, Ronald P. Messner

Research output: Contribution to journalArticle

47 Scopus citations

Abstract

It is generally thought that cyclic AMP acts as the second messenger for prostaglandin E in human lymphocytes. We have recently found that the mitogen-induced proliferation of human lymphocytes is no longer inhibited by PGE2 if the lymphocytes are preincubated overnight prior to the addition of mitogens and PGE2. In this paper we report that lymphocytes also lose their cyclic AMP response to mitogens after preincubation. The loss of sensitivity to PGE with preincubation can be blocked by cyclohexamide (25 μg/ml). Indomethacin (1 μg/ml) partially blocked the loss of sensitivity, but removal of the glass-adherent cells did not. Since either manipulation effectively stops prostaglandin production in the preincubation cultures, it would appear that indomethacin prevented the loss of sensitivity to PGE2 by a mechanism other than inhibition of PG synthetase. The addition of phytohemagglutinin to the preincubation cultures also blocked the loss of sensitivity to PGE2.

Original languageEnglish (US)
Pages (from-to)298-307
Number of pages10
JournalCellular Immunology
Volume60
Issue number2
DOIs
StatePublished - May 15 1981
Externally publishedYes

ASJC Scopus subject areas

  • Immunology

Fingerprint Dive into the research topics of 'Studies on the cyclic AMP response to prostaglandin in human lymphocytes'. Together they form a unique fingerprint.

  • Cite this